CGP 52411

CGP 52411

中文名称CGP 52411
中文同义词5,6-双(苯基氨基)-1H-异吲哚-1,3(2H)-二酮;化合物 T10782;化合物CGP52411;C275419] CGP 52411,EGFR的抑制剂
英文名称DAPH
英文同义词DAPH/CGP 52411;4,5-Dianilinophthalimide, 5,6-Bis(phenylamino)-1H-isoindole-1,3(2H)-dione, CGP 52411;DAPH-1 (DAPH;1H-Isoindole-1,3(2H)-dione, 5,6-bis(phenylamino)-;DAPH >=98% (HPLC), solid
CAS号145915-58-8
分子式C20H15N3O2
分子量329.35
EINECS号406-050-3
相关类别
Mol文件145915-58-8.mol
结构式CGP 52411 结构式

CGP 52411 性质

熔点199-202℃
密度1.374
储存条件2-8°C
溶解度二甲基亚砜:~30 mg/mL
酸度系数(pKa)9.06±0.20(Predicted)
形态固体
颜色橙色

CGP 52411 用途与合成方法

CGP52411 (DAPH) 是一种高选择性,有效,口服活性和 ATP 竞争性的 EGFR 抑制剂,IC50 为 0.3 μM。CGP52411 阻止有毒的 Ca2+ 离子流入神经元细胞,并显着抑制和逆转与阿尔茨海默症相关的 β-amyloid (Aβ42) 原纤维聚集物的形成。

EGFR

0.3 μM (IC 50 )

Amyloid-β

CGP52411 (DAPH; 0-100 μM; 90 minutes; A431 cells) treatment inhibits autophosphorylation and c-src autophosphorylation in vitro in a dose-dependent manner with IC 50 s of 1 μM and 16 μM, respectively. CGP52411 treatment also shows a concentration-dependent reduction in tyrosine phosphorylation of p185c-erbB2 with an IC 50 value of 10 μM.
CGP52411 (DAPH) inhibits c-src kinase with an IC 50 value of 16 μM. CGP52411 inhibits PKC isozymes isolated from porcine brain with an IC 50 of 80 μM. CGP52411 inhibits conventional PKC isozymes (cPKCs α, β-1, β-2, and γ) but not nonconventional PKC isozymes (nPKCs δ, ε, and ζ) or atypical PKC isozymes (aPKC η).

Western Blot Analysis

Cell Line: A431 cells
Concentration: 0 μM, 0.1 μM, 1 μM, 10 μM, 50 μM, 100 μM
Incubation Time: 90 minutes
Result: Inhibited autophosphorylation in vitro in a dose-dependent manner with an IC 50 of 1 μM. c-src autophosphorylation was inhibited with an IC 50 of 16 μM. And also resulted in a concentration-dependent reduction in tyrosine phosphorylation of p 185c-erbB2 , with an estimated IC 50 value of 10 μM.

CGP52411 (3.2 mg/kg, 6.3 mg/kg, 12.5 mg/kg, 25 mg/kg, and 50 mg/kg; oral administration; daily; for 15 days; female BALB/c nude mice) treatment in vivo against xenografts of the A431 and SK-OV-3 tumors, and has antitumor activity.

Animal Model: Female BALB/c nude mice injected with A431cells
Dosage: 3.2 mg/kg, 6.3 mg/kg, 12.5 mg/kg, 25 mg/kg, and 50 mg/kg
Administration: Oral administration; daily; for 15 days
Result: Antitumor efficacy was obtained at doses between 50 mg/kg and 6.3 mg/kg.

安全信息

安全说明36/37
WGK Germany3

MSDS信息

更新日期产品编号产品名称CAS号包装价格
2021/03/30S0745CGP 52411
CGP52411
145915-58-82mg3906.63元

CGP 52411 上下游产品信息

"CGP 52411"相关产品信息
TYRPHOSTINB48 CL-387785 N-(3-溴苯基)-6,7-二乙氧基-4-喹唑啉胺 PD168393 酪氨酸磷酸化抑制剂A51 酪氨酸磷酸化抑制剂 AG1478 酪氨酸磷酸化抑制剂23 薰草菌素 2,5-二羟基肉桂酸甲酯 酪氨酸激酶 酪氨酸磷酸化抑制剂AG825 酪氨酸磷酸化抑制剂25 卡奈替尼
主页 | 企业会员服务 | 广告业务 | 联系我们 | 旧版入口 | 中文MSDS | CAS Index | 常用化学品CAS列表 | 化工产品目录 | 新产品列表 | 评选活动 | HS海关编码 | MSDS查询 | 化工站点

Copyright © 2016-2023 ChemicalBook 版权所有  京ICP备07040585号  京公海网安备11010802032676号  

互联网增值电信业务经营许可证:京ICP证150597号  互联网药品信息服务资格证编号(京)-非经营性-2015-0073  信息系统安全等级保护备案证明(三级)  营业执照公示

根据相关法律法规和本站规定,单位或个人购买相关危险物品应取得有效的资质、资格条件。
参考《应急管理部等多部门关于加强互联网销售危险化学品安全管理的通知 (应急〔2022〕119号)》《互联网危险物品信息发布管理规定》